AMCP Announces President Elect and Three New Directors
New Board of Directors will be sworn in on Thursday, April 9 at AMCP's 27th Annual Meeting & Expo in San Diego, California.
AMCP Examines Pharmacists Attitudes on Substituting Biosimilars
A survey in JMCP finds that three-quarters of pharmacists feel confident substituting an interchangeable biosimilar for its branded biologic counterpart if the two products share the same nonproprietary name.
AMCP Applauds First Biosimilar Approval, Promotes Usage
Academy CEO Edith Rosato comments on FDA approval of the U.S.’s first biosimilar therapy.
Emerging Health Care Trends Report Released
The AMCP Foundation released Ahead of the Curve: Top 10 Emerging Health Care Trends - Implications for Patients, Providers, Payers and Pharmaceuticals. Download your copy today!
AMCP Issues Statement on CMS’s 2016 Call Letter for Medicare Programs
AMCP CEO Edith A. Rosato, RPh, IOM, commented on CMS’s release of the draft 2016 call letter for Medicare programs.
AMCP Welcomes “21st Century Cures” Provisions on Drug Abuse, Part D Fraud
The Academy applauds two provisions in draft House legislation issued recently that combat the abuse of controlled substances and payment fraud in the Medicare Part D program.
Managed Care Pharmacy Tools Brochure
AMCP has developed this easy to follow brochure that contains the best practices that provide quality care to patients and cost-effective coverage for patients, payers, employers and government.